Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment

Mònica Astals, Antònia Domingo-Salvany, Claudio Castillo Buenaventura, Jordi Tato, José Ma Vazquez, Rocío Martín-Santos, Marta Torrens

Research output: Contribution to journalArticleResearchpeer-review

59 Citations (Scopus)

Abstract

In 189 opioid-dependent subjects on methadone maintenance treatment in Barcelona (Spain), we assessed the prevalence of co-occurrence substance use and non-substance-use disorders (dual diagnosis) by the Psychiatric Research Interview for Substance and Mental Disorders [PRISM], and the impact on quality of life (HRQoL) by the SF-12 (PCS-12 and MCS-12 scales). Rates of substance and non-substance-use diagnoses were 59% and 32%, respectively. Mean scores for PCS-12 and MCS-12 were 44.1 ± 10.1 and 39.9 ± 11.7, without differences by presence or absence of dual diagnosis. Heroin users on methadone treatment showed a high prevalence of dual diagnosis and a very impaired HRQoL. Copyright © 2008 Informa Healthcare USA, Inc.
Original languageEnglish
Pages (from-to)612-632
JournalSubstance Use and Misuse
Volume43
Issue number5
DOIs
Publication statusPublished - 1 Jan 2008

Keywords

  • Dual diagnosis
  • Heroin dependence
  • Methadone
  • Psychiatric comorbidity
  • Quality of life

Fingerprint Dive into the research topics of 'Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment'. Together they form a unique fingerprint.

Cite this